Alternatives to Manifold Bio

Biotech company using AI and computational platforms to design novel peptide therapeutics.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Developing engineered biologics to harness the immune system for disease treatment.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Mapping cell-cell communication at scale in human tissue.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

MyBiotics Pharma develops innovative microbiome-based pharmabiotics and drugs using proprietary bacterial mixes and efficient delivery technologies.

Developing novel therapeutics by understanding the complex interplay of biological systems.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Drug discovery platform focused on developing therapeutics for age-related diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

Developing novel therapeutic antibodies for challenging diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Develops and manufactures biologics for therapeutic applications.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered platform for designing novel molecular structures for new medicines.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

AI platform for embryonic phenotyping that accelerates drug discovery and toxicology testing by automating analysis of embryos and organoids.

AI-powered platform accelerating biological research and drug discovery.

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

AI-driven platform for protein-level disease mapping and drug discovery.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered knowledge discovery for life sciences.

RD-Biotech develops innovative solutions for drug discovery and development using advanced biotechnology.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.